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Abstract
Catheter-related bacteraemia (CRB) is a cause of death in hospitalized patients, and parenteral nutrition (PN) is a risk factor. We aim to
describe the prognosis of PN-CRB and the impact of catheter extraction within 48 h from bacteraemia. All consecutive hospitalized adult
patients with CRB (2007–2012) were prospectively enrolled. Factors associated with 30-day mortality were determined by logistic
regression analysis. Among 847 episodes of CRB identiﬁed, 291 (34%) episodes were associated with short-term catheter use for PN. Cure
was achieved in 236 (81%) episodes, 42 (14.5%) patients died within the ﬁrst 30 days, 7 (2.5%) relapsed, and 6 (2%) had re-infection.
On multivariate analysis, previous immunosuppressive therapy (OR 5.62; 95% CI 1.69–18.68; p 0.0048) and patient age (OR 1.05; 95% CI
1.02–1.07; p 0.0009) were predictors of 30-day mortality, whereas catheter removal within 48 h of bacteraemia onset (OR 0.26; 95% CI
0.12–0.58; p 0.0010) and adequate empirical antibiotic treatment (OR 0.36; 95% CI 0.17–0.77; p 0.0081) were protective factors. Incidence
of PN-CRB decreased from 5.36 episodes/1000 days of PN in 2007 to 2.9 in 2012, yielding a 46.1% rate reduction (95% CI 15.7–65.5%),
which may be attributable to implementation of a multifaceted prevention strategy. In conclusion, short-term PN-CRB accounted for
one-third of all episodes of CRB in our setting, and 14.5% of patients died within 30 days following bacteraemia. Our ﬁndings suggest that
prompt catheter removal and adequate empirical antibiotic treatment could be protective factors for 30-day mortality. Concomitantly with
implementation of a multifaceted prevention strategy, PN-CRB incidence was reduced by half.
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Introduction
Catheter-related bacteraemia (CRB) is a common hospi-
tal-acquired infection that remains a daily concern for many
clinicians. Administration of parenteral nutrition (PN) is a
known risk factor, but there is little information on infections
caused by catheters used for PN in hospitalized patients [1,2].
In Catalonia, parenteral nutrition catheter-related bacteraemia
(PN-CRB) accounts for 25% of all cases of CRB, with a median
rate of 1.57 episodes/1000 catheter-days [3].
Catheter-related bacteraemia is considered potentially
preventable by implementation of educational campaigns for
staff focused on improving catheter care. Central-line care
bundles have proven effective for reducing CRB in intensive
care units (ICUs) [4–6], but few interventions have focused on
non-ICU areas [7]. Starting in 2008 and still ongoing, a
multifaceted strategy for CRB prevention was applied in our
hospital including various actions focusing on PN central
venous catheters (CVCs) to reduce PN-CRB (see Supporting
information, Table S1). There are no reported data in the
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literature on the impact of such measures for reducing
PN-CRB. Nor is there available information regarding the
effect of catheter removal within 48 h of bacteraemia onset on
the prognosis of PN-CRB. Hence, we aim to describe the
incidence, epidemiology and prognosis of PN-CRB in our
hospital and to evaluate the impact of catheter extraction
within 48 h from bacteraemia onset on 30-day mortality due
to this cause.
Patients and Methods
Study design, setting and study population
A prospective, observational, follow-up cohort study per-
formed from 2007 to 2012, including all adult patients
(≥18 years) diagnosed with PN-CRB admitted to Hospital
Universitari Vall d’Hebron (Barcelona, Spain), a 1200-bed
teaching hospital providing a complete range of medical and
surgical services.
In our setting, data from all adult patients hospitalized for
>48 h and with CRB are entered onto a database as part of a
continuous, laboratory-based, prospective surveillance pro-
gramme of nosocomial infections in Catalonia, named VINCat
(available at: http://vincat.gencat.cat Accessed 10 January 2014).
Within the VINCat programme, all cases of bacteraemia are
reported daily and prospectively evaluated, treated and fol-
lowed by an infectious disease specialist. Empirical and patho-
gen-speciﬁc antibiotic treatments are prescribed according to
Infectious Diseases Society of America guidelines [8] and
attending to local microbial prevalence patterns. The focus of
the present study was PN-CRB episodes occurring in our
hospital. The infection rate was calculated using the total
number of PN-CRB episodes per 1000 days of catheter use for
PN (data from the hospital pharmacy registry). As the VINCat
programme only evaluates nosocomial infections, outpatients
with home PN-CRB, patients with catheters inserted before
hospitalization, and patients hospitalized for <48 h before
bacteraemia onset were not included. Institutional review
board approval was not required because patients were treated
according to local standards of care; no clinical interventions
were made based on the data collected.
Deﬁnitions
A PN catheter was any catheter used for PN administration
during the week before the onset of bloodstream infection. In
all cases, the PN catheter had been placed during the current
hospital admission. The methods used to diagnose CRB have
been described elsewhere [3].
Multidrug-resistant organisms included methicillin-resistant
Staphylococcus aureus and Gram-negative bacteria with
acquired resistance to at least one agent in three or more
antimicrobial categories [9].
When it was indicated, empirical antibiotic treatment was
considered for suspected CRB. Empirical treatment was
deemed adequate if it showed in vitro effectiveness against
the microorganism isolated in blood cultures and had been
started within the ﬁrst 48 h after the drawing of blood samples
to investigate clinical signs and symptoms of the bloodstream
infection, referred to here as bacteraemia onset. In patients
with coagulase-negative Staphylococcus bacteraemia, antibiotic
management was considered adequate when patients with
uncomplicated CRB and no orthopaedic or intravascular
devices were managed by observation without antibiotics
once the catheter was removed, as is stated in the Infectious
Diseases Society of America catheter guidelines [8].
Cure was deﬁned as resolution of clinical signs 30 days after
CRB onset. Relapse was deﬁned as a new episode of CRB
caused by the same microorganism and diagnosed within
30 days following completion of treatment, and re-infection
was deﬁned as a new episode of CRB caused by a different
microorganism in a patient carrying the same catheter used
during the ﬁrst episode. Overall mortality included all deaths
occurring within 30 days after CRB onset.
Statistical analysis
Infection rates were calculated using the total number per year
of episodes of PN-CRB per 1000 days of PN catheter use. The
Mantel–Haenszel test was used to evaluate reductions in the
incidence of PN-CRB over the total study period.
Categorical data are expressed as the count and percentage,
and numerical data as the median and interquartile range
(IQR). The chi-square test or Fisher exact test was used to
compare categorical variables and the Mann–Whitney U-test
was used for continuous variables. All statistical tests were
two-tailed, and signiﬁcance was set at p <0.05.
Logistic regression analysis was applied to identify predictive
factors of 30-day mortality. To preserve the assumption of
independence of observations in the multivariate analysis, only
the ﬁrst episode of PN-CRB recorded for each patient was
included. Candidate variables were those with p <0.1 on
univariate analysis. In addition, variables with p values >0.1 and
considered clinically relevant based on experience and
reported data were forced into the multivariate model to
investigate their effect. Removal of the catheter within 48 h
from bacteraemia was maintained in the ﬁnal model as a ﬁxed
variable. A selection method was used based on improved
likelihood and the Akaike information criterion. Variables that
improved likelihood were gradually entered into the model
until inclusion did not improve the previous model. Potential
confounders of treatment strategies were tested. Signiﬁcant
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interactions between variables were ruled out. Results are
given as the odds ratio (OR) and 95% conﬁdence interval.
Statistical analyses were performed with SPSS, version 15.0
(SPSS; Chicago, IL, USA).
Results
During the 6-year study period, 847 consecutive CRB episodes
were identiﬁed; 291 (34%) of them were PN-CRB affecting 263
patients (median age, 64 years, IQR 49–73), 148 (56%) of
whom were men. Median Charlson comorbidity index value
was 2 (IQR 0–3), with the most common comorbidity being
malignancy in 94 (36%) patients.
Median inpatient days before CVC insertion was 9.5 (IQR
1–28) days and median duration of catheterization before CRB
onset was 13 days (IQR 8–21). Most episodes were detected
in non-ICU patients (241, 83%), mainly patients in surgical
areas (157, 54%). There were no differences in the length of
PN catheterization between non-ICU and ICU patients
(13 days; IQR 8.75–21 versus 12 days; IQR 8–21, p 0.56).
Central venous catheters were affected in 223 (77%)
episodes, peripherally inserted CVCs in 62 (21%) episodes,
and peripheral venous catheters in 6 (2%) episodes. In patients
with CVCs, the venous access was subclavian in 159 (55%)
cases, femoral in 43 (15%), and jugular in 21 (7%).
Microorganisms causing PN-CRB and those causing bacter-
aemia related to catheters used for other purposes are shown
in Table 1. Staphylococcus spp. were the most common
causative agents in both PN-CRB and non-PN-CRB, with
coagulase-negative Staphylococcus being more frequent in
PN-CRB and S. aureus in non-PN-CRB. Candida spp. were
more commonly found on catheters used for PN than on
those used for other purposes: 60 (21%) versus 23 (4%) (p
<0.001). Non-albicans Candida species were identiﬁed in 24
(40%) cases of PN catheter-related candidaemia, with 17 of
them caused by Candida parapsilosis.
Data regarding PN catheter management, empirical antibi-
otic treatments and outcome, sorted by aetiology, are shown
in Table 2. Focusing on PN catheter management, catheters
were removed in 274 (94%) episodes, retained in 13 (5%), and
in four episodes catheter management was not recorded. The
reason for not removing the catheter was patient death in nine
cases and use of antibiotic-lock plus systemic antibiotics in
four. Median time from bacteraemia to catheter removal was
1 day (IQR 0–2 days); in 226 (79%) episodes the catheter was
removed within 48 h after bacteraemia onset.
Appropriate empirical antimicrobial therapy was adminis-
tered in 157/284 (55%) cases (in seven cases, these data were
missing). Stratifying by microbiological aetiology, empirical
antibiotic treatment was adequate in most PN-CRB episodes
caused by Gram-positive microorganisms (131/171, 77%), but
in only 12 of 30 cases (40%) caused by multidrug-resistant
organisms.
Cure was achieved in 236 (81%) episodes, 42 (14.5%)
patients died within 30 days after onset of infection (24 (8%)
within the ﬁrst 7 days), 7 (2.5%) relapsed, and 6 (2%) had a
re-infection.
Over the 6-year study period, there was a sustained
decrease in the incidence of PN-CRB from 5.36 episodes/
1000 days of PN catheter use in 2007 to 2.9 epi-
sodes/1000 days in 2012; that is, a rate reduction of 46.1%
(95% CI 15.7–65.54%) (Fig. 1). The trend of the median rate
reduction for the overall period was statistically signiﬁcant
(p 0.00082).
Multivariate logistic regression analysis was performed to
explore predictive factors of 30-day mortality (Table 3).
Previous immunosuppressive therapy (OR 5.62; 95% CI
1.69–18.68; p 0.0048) and patient age (OR 1.05; 95% CI
1.02–1.07; p 0.0009) were independent predictors of 30-day
mortality, whereas catheter removal within 48 h after bacter-
aemia onset (OR 0.269; 95% CI 0.12–0.58; p 0.0010) and
adequate empirical antibiotic treatment (OR 0.36; 95% CI
0.17–0.77; p 0.0081) were protective factors.
TABLE 1. Microorganisms causing parenteral nutrition cath-
eter-related bacteraemia (PN-CRB) (n = 291) and those
causing bacteraemia related to catheters used for other
purposes (n = 556)
PN-CRB
n = 291 (100%)
Non-PN-CRB
n = 556 (100%) p
Gram-positive cocci 175 (60) 399 (72) 0.001
Coagulase-negative
staphylococci
149 (51) 222 (40) 0.002
Methicillin-sensitive
Staphylococcus aureus
13 (4) 99 (18) <0.001
Methicillin-resistant
Staphylococcus aureus
9 (3) 48 (8.5) 0.002
Enterococcus spp. 4 (1) 28 (5) 0.008
Streptococcus spp. 0 (0) 2 (0.5) 0.306
Candida spp. 60 (21) 23 (4) <0.001
Candida albicans 36 (13) 10 (1.7) <0.001
Non-albicans Candida 24 (8) 13 (2.3) <0.001
Gram-negative bacilli 42 (14) 107 (19) 0.081
Klebsiella spp. 14 (5) 21 (3.7) 0.473
Pseudomonas aeruginosa 13 (4) 31 (5.5) 0.490
Enterobacter spp. 8 (3) 26 (4.5) 0.175
Escherichia coli 2 (0.5) 13 (2.3) 0.084
Acinetobacter baumannii 2 (0.5) 2 (0.5) 0.509
Serratia marcescens – 11 (2) –
Miscellaneousa 3 (1) 3 (0.5) –
Polymicrobial
bloodstream infectionsb
15 (5) 27 (5) 0.849
aMiscellaneous infection includes one Proteus mirabilis, one Citrobacter spp. and one
Serratia spp. for PN-CRB and two Morganella morganii and one Proteus mirabilis for
non-PN-CRB.
bPolymicrobial bloodstream infections in PN-CRB include a mixed infection due to
Candida spp. and Gram-positive cocci (GPC) in six cases, two different
Gram-negative bacilli (GNB) in ﬁve cases, two different GPC in three, and
Candida spp. and GNB in one. Non-PN-CRB mixed infections include a GNB and
GPC in 12 cases, two different GNB in nine cases, two different GPC in four cases
and Candida spp. and GPC in two cases.
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Discussion
To our knowledge, this is the largest study investigating CRB in
patients with temporary catheters for PN, accounting for
one-third of all CRB cases occurring in our hospital. Our study
identiﬁes the risk factors associated with 30-day mortality, and
suggests the effectiveness of a multifaceted strategy for
PN-CRB prevention.
Parenteral nutrition is a recognized risk factor for CRB, an
infection occurring in 1.3–26.2% of patients receiving PN
[3,10–14]. Nonetheless, published information is scarce
regarding PN-CRB in patients with temporary catheters
[1,2]. In our study, 83% of PN-CRB episodes were detected
outside the ICU, mainly in surgical wards, probably because
nutritional requirement after surgery is the most common
reason for PN prescription.
Femoral venous catheterization has been considered a
major risk factor for CRB [15] because the groin area is
subject to considerable movement and potential contamina-
tion from urine and faecal matter. Hence, current educational
campaigns are attempting to reduce femoral access in favour of
subclavian placement. In our series, femoral CVCs had been
used in 15% of PN-CRB episodes and we consider this result a
target for improvement.
Regarding the microbiological data, Gram-positive cocci
were the most common microorganisms isolated in blood
cultures, coagulase-negative Staphylococcus, responsible for
51% of all PN-CRBs, were the most frequent microorganisms
identiﬁed, in accordance with the results of other studies,
which have reported incidences up to 69% of cases [2,16–18].
Candida spp. were the second most isolated microorganisms in
frequency, accounting for 21% of cases. Parenteral nutrition
has traditionally been associated with CRB due to Candida spp.,
particularly C. albicans, although the related literature is limited
[2,10,18,19]. Marra et al. [18] reported that fungi accounted
for 22% of CRBs in long-term PN-CRB, a percentage similar to
our 21%. Candida-caused bloodstream infections are common
in immunocompromised and ICU patients, but they are also
common in patients who have undergone recent abdominal
surgery and in those receiving broad-spectrum antibiotics [20].
Overall 157 (54%) of our PN-CRB episodes were diagnosed in
patients in surgical areas; therefore we believe that this could
explain, at least in part, the high incidence of candidaemia in
our series.
We found that 14.5% of our patients died within 30 days of
PN-CRB onset. In critically ill patients, the attributable
mortality of CRB and fungaemia in the USA ranges from 2%
to 35% [21,22], rates in accordance with our results. Braun
et al. [23] described an increase in CRB-associated mortality
concomitantly with a shift towards Gram-negative bacteria in
their institution; however, we have not observed this shift in
our hospital. To our knowledge, there are no recent data on
CRB-associated mortality focusing in non-critically ill patients
and no data on PN-CRB-associated mortality.
Catheter removal within the ﬁrst 48 h following CRB onset
and adequate empirical antibiotic treatment were protective
factors. Catheter removal in septic patients is considered the
standard of care [8], and this practice agrees with the












Adequate empirical antibiotic therapya 131/171 (77)a 3/59 (5)a 19/40 (48)a 4/14 (29)a 157/284 (55)a
PN-catheter withdrawal within ﬁrst
48 hours from bacteraemiab
130/170(76)b 49/60 (82) 36/42 (86) 11/15 (73) 226/287 (79)b
Cured 147 (84) 47 (79) 31 (74) 11 (73) 236 (81)
Death
Early death (0–7 days) 10 (6) 7 (12) 4 (9.5) 3 (20) 24 (8.3)
Late death (8–30 days) 10 (6) 3 (4) 4 (9.5) 1 (7) 18 (6.2)
Relapsed 3 (2) 2 (3) 2 (5) – 7 (2.4)
Re-infection 4 (2) 1 (2) 1 (2) – 6 (2.1)
aData on empirical antibiotic therapy was missing in seven cases (three Gram-positive cocci CRB, two Gram-negative CRB, one catheter-related candidaemia, and one
polymicrobial CRB).
bData on catheter management were missing in four cases of PN-CRB cause by Gram-positive cocci.
FIG. 1. Incidence of parenteral nutrition catheter-related bactera-
emia (PN-CRB) (episodes/1000 days of catheter use for parenteral
nutrition).
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observations in our series, where most PN catheters were
removed within the ﬁrst 48 h of bacteraemia. Permanent
catheters, such as tunnelled catheters, are not included in our
study. Withdrawal of PN catheters is not as much of a problem
as removal of permanent CVCs, because patients usually have
an alternative venous access and PN can be discontinued, at
least temporarily, when bacteraemia is diagnosed. These
factors may explain the high percentage of early catheter
removal in our series. Prompt initiation of appropriate
antibiotic treatment is also a prognostic determinant. Knowl-
edge of local epidemiology and the particular characteristics
and risk factors of each patient are the keys to choosing an
appropriate antibiotic.
During the period studied, the aggregate median incidence
of PN-CRB dropped by 46% following implementation of a
global prevention strategy, suggesting its effectiveness. Inci-
dence of PN-CRB has not been extensively described; available
studies report values ranging from 13.1 per 1000 PN-days in
patients outside the ICU [14,17] to 25 per 1000 PN-days in
studies including all hospitalized patients [16]. In our case,
establishment of a surveillance programme highlighted the true
burden of this infection and the need for an intervention.
Collins et al. [2] reported an overall reduction in PN-CRBs
from 33.6 cases/1000 catheter-days in 1997 to 6.8 cases/1000
catheter-days in 2008. The authors attributed these favourable
results to creation of a PN support team to promote high
standards in CVC insertion and care, and to regular infection
audit meetings to monitor trends in CRB [24]. Current
guidelines for the prevention of intravascular CRB recommend
educational programmes [25], and the effectiveness of cen-
tral-line care bundles has been well demonstrated [4–7]. As an
example of the efﬁcacy of these measures, Seisdedos et al. [17]
reported that there were no cases of PN-CRB in critically ill
patients after the Zero Bacteremia project was implemented in
their ICU. In our institution, a global strategy for CRB
prevention achieved a signiﬁcant reduction in overall PN-CRB
rates.
The observations presented are subject to limitations. First,
this was not a randomized study, with the resulting risk of bias
due to various confounding factors, such as the fact that all
preventive measures are more carefully applied when one is
being observed. Second, the components of PN solutions can
support microbial growth, but the composition of PN
solutions used in our patients was not investigated, so we
were unable to assess the impact of this factor on PN-CRB.
Third, although malnutrition is considered a relevant risk
factor for PN-CRB [10], there were no available data on the
nutritional status of our patients, so the role of this factor
could not be evaluated. Nonetheless, the prospective design of
a multimodal intervention programme for CRB prevention and
the uniform patient management by a specialized multidisci-
plinary team are both strengths of the study.
In conclusion, PN-CRB accounts for one-third of all CRB
episodes in our setting and 14.5% of patients with PN-CRB die
within 30 days. Immunosuppression and patient age are risk
factors for 30-day mortality, whereas catheter removal within
48 h after PN-CRB and adequate empirical antibiotic treat-
ment may lead to a reduction in the PN-CRB rate. Concom-
itant with implementation of a multifaceted prevention
strategy, PN-CRB incidence dropped by half.
Acknowledgements
We thank Celine Cavallo for English language support and
Prof. Santiago Perez-Hoyos for statistical and methodological
assistance. This study was presented in part at the 52nd
Interscience Conference on Antimicrobial Agents and Che-




n = 41 (16%)
Alive
n = 222 (84%)
Univariate analysis Multivariate analysis
OR (95% CI) p OR (95% CI) p
Age, years 73 (62.5–80) 61.5 (47–71) 1.04 (1.02–1.07) 0.001 1.05 (1.02–1.07) 0.0009
Male sex 25 (61) 124 (56) 1.23 (0.62–2.44) 0.543 – –
Charlson Comorbidity Index score 2 (1–3) 2 (0–3) 1.16 (0.97–1.39) 0.098 – –
Malignancy 17/39 (44) 77/215 (36) 1.38 (0.69–2.76) 0.355 – –
Diabetes mellitus 8/39 (20) 38/215 (18) 1.20 (0.51–2.82) 0.672 – –
Immunosuppressive treatment 6/39 (15) 11/215 (5) 3.37 (1.17–9.74) 0.018 5.62 (1.69–18.68) 0.0048
Femoral catheter location 8 (19) 30 (13) 1.55 (0.65–3.68) 0.316 – –
PN-CRB due to Gram-positive cocci 20 (50) 134 (60) 0.62 (0.32–1.22) 0.167 – –
PN-CRB due to Candida spp. 9 (22) 48 (22) 1.02 (0.46–2.28) 0.962 – –
PN-CRB due to Gram-negative bacilli 8 (19) 33 (15) 1.39 (0.59–3.27) 0.451 – –
PN-CRB due to polymicrobial infection 3 (7) 11 (5) 1.51 (0.40–5.68) 0.536 – –
CRB caused by multidrug-resitant organisms 7 (17) 23 (10) 1.78 (0.71–4.47) 0.214 – –
Catheter removal within 48 h after PN-CRB 26 (63) 178/219 (81) 0.40 (0.19–0.82) 0.011 0.26 (0.12–0.58) 0.001
Adequate empirical antibiotic treatment 15 (37) 125/218 (57) 0.43 (0.21–0.86) 0.014 0.36 (0.17–0.77) 0.0081
Categorical data are expressed in absolute number (percentage); continuous variables are expressed in median (interquartile range).
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